Chap 1. Executive Summary
Chap 2. Market Determinants
2.1. Key Drivers
2.1.1. Better choice over conventional methods
2.1.2. Customized products
2.1.3. Research and Development
2.1.4. Innovative and advanced technologies
2.1.5. FDA nod to 3D innovative technologies
2.2. Restraints
2.2.1. High cost to individual patient
2.2.2. Lower Adoption rate
2.2.3. Regulations
2.3. Opportunity
2.3.1. Increase in joint replacement surgeries
2.3.2. Medical Tourism
2.3.3. Bio printing technology
2.4. Challenges
2.4.1. Transplantation of vital organs
2.4.2. High adoption rate of 3D technology is a challenge
2.4.3. Regulations are a hindrance for 3D technology
Chap 3. 3D technology in healthcare - Application
3.1. 3D Printing
3.2. Implants
3.2.1. Example of use of 3D printing in implant
3.2.2. Advantages of 3D printing in healthcare
3.2.3. Dental Implants
3.2.4. Bio Engineering
3.2.5. Bio medical applications of 3D printing
3.3. 3D printing technologies
3.3.1. Electron beam melting
3.3.2. Laminated object manufacturing
3.3.3. Thermal Inkjet Printing
3.3.4. Selective Laser Sintering
3.3.5. Fused Deposition Modeling (FDM)
3.3.6. Photo polymerization
3.4. Raw material used for 3D printing in healthcare
3.4.1. Bio Ink
3.4.2. Ceramic
3.4.3. Polymers
3.4.4. Acrylonitrile Butadiene Styrene (ABS)
3.4.5. Polyactic Acid (PLA)
3.4.6. Metal
3.5. 3D Imaging
3.5.1. 3D mammography
3.5.2. 3D computed tomography
3.6. Virtual Reality
3.6.1. Use of virtual reality in therapy
Chap 4. Strategies to stay competitive in the 3D technology market in healthcare
4.1. Research and development give rise to innovative technologies
4.2. Stratasys partners with Worrell for new 3D printed medical devices
4.2.1. Organovo and Johnson & Johnson enter into partnership for 3D bio printing drug discovery research
4.2.2. Organovo enters into partnership with the Yale School of Medicine for 3D bioprinted tissue project
4.3. Acquisition gives upper hand over the competitors
4.3.1. Case Study
Chap 5. Geographical analysis
5.1. North America
5.1.1. United States
5.1.2. Canada
5.2. Europe
5.2.1. Regulations regarding medical devices in Europe
5.2.2. Prevalent diseases in Europe
5.2.3. United Kingdom (UK)
5.2.4. France
5.2.5. Germany
5.3. Asia Pacific (APAC)
5.3.1. China
5.3.1.1. Diseases prevalence in China
5.3.2. Japan
5.3.2.1. Regulations in Japan
5.3.3. India
Chap 6. Company Profiling
6.1. 3 D Imaging
6.1.1. GE Healthcare
6.1.1.1. Overview
6.1.1.2. Strategic Moves
6.1.1.3. SCOT Analysis
6.1.2. Siemens Healthcare
6.1.2.1. Overview
6.1.2.2. Siemens Healthcare Products Portfolio
6.1.2.3. Strategic Moves (2013-14)
6.1.2.4. SCOT Analysis
6.1.3. Philips Healthcare
6.1.3.1. Overview
6.1.3.2. Phillips Healthcare Products Portfolio
6.1.3.3. Strategic Moves (2013-14)
6.1.3.4. SCOT Analysis
6.1.4. Toshiba Medical Systems
6.1.4.1. Overview
6.1.4.2. Toshiba Medical System Products Portfolio
6.1.4.3. Strategic Moves (2013-14)
6.1.4.4. SCOT Analysis
6.1.5. BARCO NV
6.1.5.1. Overview
6.1.5.2. BARCO NV Products Portfolio
6.1.5.3. Strategic Moves (2013-14)
6.1.5.4. SCOT Analysis
6.1.6. Hitachi Medical Systems
6.1.6.1. Overview
6.1.6.2. Hitachi Medical System Products Portfolio
6.1.6.3. Strategic Moves (2013-14)
6.1.6.4. SCOT Analysis
6.2. 3 D Printing
6.2.1. Stryker
6.2.1.1. Overview
6.2.1.2. Strategic Moves (2013-14)
6.2.1.3. SCOT Analysis
6.2.2. 3D Systems Corporation
6.2.2.1. Overview
6.2.2.2. SCOT Analysis
6.2.3. Stratasys
6.2.3.1. Overview
6.2.3.2. SCOT Analysis
6.2.4. Arcam AB
6.2.4.1. Overview
6.2.4.2. SCOT Analysis
6.2.5. Envision TEC GMBH
6.2.5.1. Overview
6.2.5.2. SCOT Analysis
6.2.6. Materialise NV
6.2.6.1. Overview:
6.2.6.2. SCOT Analysis
Table List
TABLE 1 Global 3D technology in healthcare market, 2013-2021 (in $million)
TABLE 2 Cost of Implantations, conventional method in 2011
TABLE 3 Global 3D printing in healthcare market, 2013-2021 (in $million)
TABLE 4 Global 3D printing in healthcare market, 2013-2021 (in $million)
TABLE 5 Price comparison between filament of ABS and PLA (2013)
TABLE 6 Global 3D imaging in healthcare market, 2013-2021 (in $million)
TABLE 7 Global 3D imaging in healthcare market, 2013-2021 (in $million)
TABLE 8 Global 3D virtual reality in healthcare market, 2013-2021 (in $million)
TABLE 9 Global 3D technology in healthcare Market, 2013-2021 (in $million)
TABLE 10 North American 3D technology Market, 2013-2021 (in $million)
TABLE 11 Factsheet (US health records 2011 and 2012)
TABLE 12 European 3D technology Market, 2013-2021 (in $million)
TABLE 13 Prevalence of Heart Diseases in UK (2013)
TABLE 14 GE Healthcare’s Product Portfolio
Figures List
FIGURE 1 Supply chain in 3 D healthcare 17
FIGURE 2 Global 3D printed implants market, 2013-2021 (in $million)
FIGURE 3 Market Share by regions (2013, in $million)
FIGURE 4 United States 3D technology Market, 2013-2021 (in $million)
FIGURE 5 Canada 3D technology Market, 2013-2021 (in $million)
FIGURE 6 UK 3D technology Market, 2013-2021 (in $million)
FIGURE 7 France 3D technology Market, 2013-2021 (in $million)
FIGURE 8 Germany 3D technology Market, 2013-2021 (in $million)
FIGURE 9 APAC 3D technology Market, 2013-2021 (in $million)
FIGURE 10 China 3D technology Market, 2013-2021 (in $million)
FIGURE 11 Japan 3D technology Market, 2013-2021 (in $million)
FIGURE 12 India 3D technology Market, 2013-2021 (in $million)
